890
Views
21
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Acute promyelocytic leukemia during pregnancy: a systematic analysis of outcome

, , , &
Pages 616-622 | Received 01 Mar 2015, Accepted 19 Jun 2015, Published online: 28 Jul 2015

References

  • Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control 2008;19:379–390.
  • Ades L, Guerci A, Raffoux E, et al. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood 2010;115:1690–1696.
  • Powell BL, Moser B, Stock W, et al. Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Blood 2010;116:3751–3757.
  • Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 2013;369: 111–121.
  • Park JH, Qiao B, Panageas KS, et al. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood 2011;118:1248–1254.
  • Lehmann S, Ravn A, Carlsson L, et al. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia 2011;25:1128–1134.
  • Stern RS, Rosa F, Baum C. Isotretinoin and pregnancy. J Am Acad Dermatol 1984;10:851–854.
  • Franchini M, Di Minno MN, Coppola A. Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost 2010;36:388–403.
  • Tallman MS, Kwaan HC. Intravascular clotting activation and bleeding in patients with hematologic malignancies. Rev Clin Exp Hematol 2004;8:E1.
  • Alegre A, Chunchurreta R, Rodriguez-Alarcon J, et al. Successful pregnancy in acute promyelocytic leukemia. Cancer 1982;49:152–153.
  • Ali R, Ozkalemkas F, Ozcelik T, et al. Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. Leuk Res 2003;27:381–385.
  • Bhoopathi B, Ostapowicz F, Bazley W. Acute promyelocytic leukemia in pregnancy. Obstet Gynecol 1973;41:275–278.
  • Celo JS, Kim HC, Houlihan C, et al. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option. Obstet Gynecol 1994;83:808–811.
  • Chelghoum Y, Vey N, Raffoux E, et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 2005;104:110–117.
  • Consoli U, Figuera A, Milone G, et al. Acute promyelocytic leukemia during pregnancy: report of 3 cases. Int J Hematol 2004;79: 31–36.
  • Delgado-Lamas JL, Garces-Ruiz OM. Malignancy: case report: acute promyelocytic leukemia in late pregnancy. Successful treatment with all-trans-retinoic acid (ATRA) and chemotherapy. Hematology 2000;4:415–418.
  • D’Emilio A, Dragone P, De Negri G, et al. Acute myelogenous leukemia in pregnancy. Haematologica 1989;74:601–604.
  • Ewing PA, Whittaker JA. Acute leukemia in pregnancy. Obstet Gynecol 1973;42:245–251.
  • Fadilah SA, Hatta AZ, Keng CS, et al. Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid. Leukemia 2001;15:1665–1666.
  • Fassas A, Kartalis G, Klearchou N, et al. Chemotherapy for acute leukemia during pregnancy. Five case reports. Nouv Rev Fr Hematol 1984;26:19–24.
  • Ganzitti L, Fachechi G, Driul L, Marchesoni D. Acute promyelocytic leukemia during pregnancy. Fertil Steril 2010;94:2330 e2335–2336.
  • Giagounidis AA, Beckmann MW, Giagounidis AS, et al. Acute promyelocytic leukemia and pregnancy. Eur J Haematol 2000; 64:267–271.
  • Greenlund LJ, Letendre L, Tefferi A. Acute leukemia during pregnancy: a single institutional experience with 17 cases. Leuk Lymphoma 2001;41:571–577.
  • Hoffman MA, Wiernik PH, Kleiner GJ. Acute promyelocytic leukemia and pregnancy. A case report. Cancer 1995;76:2237–2241.
  • Incerpi MH, Miller DA, Posen R, et al. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy. Obstet Gynecol 1997;89:826–828.
  • Lee DD, Park TS, Lee DS, et al. Acute promyelocytic leukemia in late pregnancy with unusual secondary chromosomal change and its prognostic importance. Cancer Genet Cytogenet 2005;157:92–93.
  • Lim G, Cho EH, Cho SY, et al. A novel PML-ADAMTS17-RARA gene rearrangement in a patient with pregnancy-related acute promyelocytic leukemia. Leuk Res 2011;35:e106–110.
  • Nakamura K, Dan K, Iwakiri R, et al. Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid. Ann Hematol 1995;71:263–264.
  • Park TS, Lee ST, Kim JS, et al. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts. Cancer Genet Cytogenet 2009;188:48–51.
  • Sanz MA, Rafecas FJ. Successful pregnancy during chemotherapy for acute promyelocytic leukemia. N Engl J Med 1982;306:939.
  • Stentoft J, Nielsen JL, Hvidman LE. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy. Leukemia 1994;8: 1585–1588.
  • Takatsuki H, Abe Y, Goto T, et al. [Two cases of acute promyelocytic leukemia in pregnancy and the effect of anthracyclines on fetal development]. Rinsho Ketsueki 1992;33:1736–1740.
  • Terada Y, Shindo T, Endoh A, et al. Fetal arrhythmia during treatment of pregnancy-associated acute promyelocytic leukemia with all-trans retinoic acid and favorable outcome. Leukemia 1997; 11:454–455.
  • Troitskaia VV, Parovichnikova EN, Sokolov AN, et al. [Treatment for acute promyelocytic leukemia during pregnancy]. Ter Arkh 2013;85:56–63.
  • Watanabe R, Okamoto S, Moriki T, et al. Treatment of acute promyelocytic leukemia with all-trans retinoic acid during the third trimester of pregnancy. Am J Hematol 1995;48:210–211.
  • Breccia M, Cimino G, Alimena G, et al. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation. Haematologica 2002;87:ELT12.
  • Gstottner M, Frisch H, Dienstl F. [Delivery of a normal child after chemotherapy of acute promyelocytic leukaemia during pregnancy (author's trans.)]. Blut 1978;36:171–174.
  • Maeda M, Tyugu H, Okubo T, et al. [A neonate born to a mother with acute promyelocytic leukemia treated by all-trans retinoic acid]. Rinsho Ketsueki 1997;38:770–775.
  • Aoki A, Yoneda N, Yoneda S, et al. Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia. J Obstet Gynaecol Res 2011;37:1759–1763.
  • Bartsch HH, Meyer D, Teichmann AT, et al. Treatment of promyelocytic leukemia during pregnancy. A case report and review of the literature. Blut 1988;57:51–54.
  • Nakajima Y, Hattori Y, Ito S, et al. Acute leukemia during pregnancy: an investigative survey of the past 11 years. Int J Lab Hematol 2015;37:174–80.
  • Lin CP, Huang MJ, Liu HJ, et al. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin. Am J Hematol 1996;51:251–252.
  • Carradice D, Austin N, Bayston K, et al. Successful treatment of acute promyelocytic leukaemia during pregnancy. Clin Lab Haematol 2002;24:307–311.
  • Lipovsky MM, Biesma DH, Christiaens GC, et al. Successful treatment of acute promyelocytic leukaemia with all-trans-retinoic-acid during late pregnancy. Br J Haematol 1996;94:699–701.
  • Itoh M, Takao S, Yago K, Shimada H. [Successful treatment of acute promyelocytic leukemia in a pregnant patient with all-trans retinoic acid and chemotherapy resulting in a safe delivery]. Rinsho Ketsueki 2003;44:401–403.
  • Tsuda H, Doi H, Inada T, et al. [Successful treatment of acute promyelocytic leukemia in a pregnant woman by using all-trans retinoic acid]. Rinsho Ketsueki 1994;35:717–719.
  • Harrison P, Chipping P, Fothergill GA. Successful use of all-trans retinoic acid in acute promyelocytic leukaemia presenting during the second trimester of pregnancy. Br J Haematol 1994;86: 681–682.
  • Katagiri S, Tsubakio T, Minami G, et al. Successful embolization for uterine hemorrhage in a patient with acute promyelocytic leukemia. Acta Haematol 1983;70:119–121.
  • Sham RL. All-trans retinoic acid-induced labor in a pregnant patient with acute promyelocytic leukemia. Am J Hematol 1996; 53:145.
  • Siu BL, Alonzo MR, Vargo TA, et al. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 2002;12:399–402.
  • Wallace PJ. Complete remission in acute promyelocytic leukemia despite the persistence of the 15;17 translocation. Am J Hematol 1989;31:266–268.
  • Sanz MA, Montesinos P, Casale MF, et al. Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia. Ann Hematol 2015;94:1357–61.
  • Committee Opinion No 579: Definition of term pregnancy. Obstetr Gynecol 2013;122:1139–1140.
  • Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood 2012;119:34–43.
  • Thomas X. Acute myeloid leukemia in the pregnant patient. Eur J Haematol 2015 doi: 10.1111/ejh.12535 [Epub ahead of print].
  • Shapira T, Pereg D, Lishner M. How I treat acute and chronic leukemia in pregnancy. Blood Rev 2008;22:247–259.
  • Ioachim HL. Non-Hodgkin's lymphoma in pregnancy. Three cases and review of the literature. Arch Pathol Lab Med 1985;109: 803–809.
  • Shakhar K, Valdimarsdottir HB, Bovbjerg DH. Heightened risk of breast cancer following pregnancy: could lasting systemic immune alterations contribute? Cancer Epidemiol Biomarkers Prev 2007;16:1082–1086.
  • Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med 1985;313:837–841.
  • Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283–291.
  • Turchi JJ, Villasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer 1988;61:435–440.
  • Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin Oncol 1989;16:388–396.
  • Golub MS, Macintosh MS, Baumrind N. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. J Toxicol Environ Health B Crit Rev 1998;1:199–241.
  • Breccia M, Molica M, Efficace F, et al. Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid. Br J Haematol 2014;167:428–430.
  • Gupta S, Bagel B, Gujral S, et al. Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series. Leuk Lymphoma 2012;53:2192–2194.
  • Ades L, Sanz MA, Chevret S, et al. Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood 2008;111:1078–1084.
  • Rashidi A, Riley M, Goldin TA, et al. Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia: final results of a multicentric study in the United States. Leuk Res 2014;38:1036–1040.
  • Sanz MA, Grimwade D, Tallman MS, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009;113:1875–1891.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.